These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 25727728)

  • 1. Lentigines in resolving psoriatic plaques: rarely reported sequelae in pediatric cases.
    LaRosa CL; Foulke GT; Feigenbaum DF; Cordoro KM; Zaenglein AL
    Pediatr Dermatol; 2015; 32(3):e114-7. PubMed ID: 25727728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eruptive lentiginosis in resolving psoriatic plaques.
    Micieli R; Alavi A
    JAAD Case Rep; 2018 May; 4(4):322-326. PubMed ID: 29693059
    [No Abstract]   [Full Text] [Related]  

  • 3. Biologic response modifiers and pediatric psoriasis.
    Bellodi Schmidt F; Shah KN
    Pediatr Dermatol; 2015; 32(3):303-20. PubMed ID: 25727936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of severe psoriasis in an adolescent with ustekinumab.
    AbuHilal M; Ho N
    Pediatr Dermatol; 2015; 32(3):377-80. PubMed ID: 25727845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormones in male psoriasis patients and their correlation with the Psoriasis Area and Severity Index.
    Cemil BC; Cengiz FP; Atas H; Ozturk G; Canpolat F
    J Dermatol; 2015 May; 42(5):500-3. PubMed ID: 25728622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy.
    Tsimberidou AM; Said R; Culotta K; Wistuba I; Jelinek J; Fu S; Falchook G; Naing A; Piha-Paul S; Zinner R; Siddik ZH; He G; Hess K; Stewart DJ; Kurzrock R; Issa JP
    Clin Epigenetics; 2015; 7(1):29. PubMed ID: 25806091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission.
    Takahashi K; Roh W; Zhang J; Propotopov A; Patel K; Strickland S; Kim A; Vnencak-Jones C; Pelletier S; Parmar S; Garcia-Manero G; Kornblau S; Chin L; Kantarjian H; Futreal PA; Ravandi F
    Am J Hematol; 2015 Jul; 90(7):E134-5. PubMed ID: 25801490
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural history and risk factors of atopic dermatitis in children.
    Pyun BY
    Allergy Asthma Immunol Res; 2015 Mar; 7(2):101-5. PubMed ID: 25729616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.
    Colombel JF; Reinisch W; Mantzaris GJ; Kornbluth A; Rutgeerts P; Tang KL; Oortwijn A; Bevelander GS; Cornillie FJ; Sandborn WJ
    Aliment Pharmacol Ther; 2015 Apr; 41(8):734-46. PubMed ID: 25728587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of adalimumab therapy in patients with ulcerative colitis previously treated with infliximab: a Danish single-center cohort study.
    Christensen KR; Steenholdt C; Brynskov J
    Scand J Gastroenterol; 2015 Aug; 50(8):1018-24. PubMed ID: 25861832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE).
    Thaçi D; Humeniuk J; Frambach Y; Bissonnette R; Goodman JJ; Shevade S; Gong Y; Papavassilis C;
    Br J Dermatol; 2015 Sep; 173(3):777-87. PubMed ID: 25823958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of leptin with adiposity and inflammation and resistin with disease severity in psoriatic patients undergoing anti-TNF-alpha therapy.
    Pina T; Genre F; Lopez-Mejias R; Armesto S; Ubilla B; Mijares V; Dierssen-Sotos T; Gonzalez-Lopez MA; Gonzalez-Vela MC; Blanco R; Hernández JL; Llorca J; Gonzalez-Gay MA
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1995-2001. PubMed ID: 25823684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral gene expression in psoriasis.
    Raposo RA; Gupta R; Abdel-Mohsen M; Dimon M; Debbaneh M; Jiang W; York VA; Leadabrand KS; Brown G; Malakouti M; Arron S; Kuebler PJ; Wu JJ; Pillai SK; Nixon DF; Liao W
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1951-7. PubMed ID: 25809693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature.
    Campanati A; Ganzetti G; Martina E; Giannoni M; Gesuita R; Bendia E; Giuliodori K; Sandroni L; Offidani A
    Int J Dermatol; 2015; 54(5):e109-14. PubMed ID: 25808243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
    Ross C; Marshman G; Grillo M; Stanford T
    Australas J Dermatol; 2016 May; 57(2):137-40. PubMed ID: 25754697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perianal Crohn's disease: a review.
    Juncadella AC; Alame AM; Sands LR; Deshpande AR
    Postgrad Med; 2015 Apr; 127(3):266-72. PubMed ID: 25746229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation biologics in the management of plaque psoriasis: a literature review of IL-17 inhibition.
    Yamauchi PS; Bagel J
    J Drugs Dermatol; 2015 Mar; 14(3):244-53. PubMed ID: 25738846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eruptive lentigines confined to psoriatic plaques following biologic therapy.
    Khanna U; Oprea Y; Fisher M; Halverstam C
    Clin Rheumatol; 2022 Oct; 41(10):3257-3258. PubMed ID: 35816253
    [No Abstract]   [Full Text] [Related]  

  • 19. Eruptive lentiginosis in resolving psoriatic plaques.
    Micieli R; Alavi A
    JAAD Case Rep; 2018 Oct; 4(9):924-929. PubMed ID: 30320197
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of solar lentigines using a combination of picosecond laser and biophotonic treatment.
    Scarcella G; Dethlefsen MW; Nielsen MCE
    Clin Case Rep; 2018 Sep; 6(9):1868-1870. PubMed ID: 30214780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.